Charles S. Ryan serves as Executive at BioRestorative Therapies, Inc., where they oversee executive responsibilities. Since joining the company, Charles S. Ryan has executed 6 insider transactions totaling $106.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 23, 2026 involved receiving (via award) 200,000 shares valued at $0.
Charles S. Ryan currently holds 200,000 shares of BioRestorative Therapies, Inc. (BRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles S. Ryan has been a net buyer of BRTX stock. They have purchased $106.5K and sold $0 worth of shares.
Charles S. Ryan's most recent insider trade was on Jan 23, 2026, when they sold 200,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.65 |
| Discretionary |
| Jun 28, 2017 | APDN | $25.0K | Award | 14,205 | $1.76 | Discretionary |
| Mar 1, 2017 | BRTX | $80.0K | Award | 26,667 | $3.00 | Discretionary |
| Dec 7, 2015 | BRTX | $25.0K | Purchase | 6,250 | $4.00 | Discretionary |
| May 8, 2015 | BRTX | $50.0K | Purchase | 200,000 | $0.25 | Discretionary |